Referencias bibliográficas

  1. Park, K. H., & Park, W. J. (2015). Endothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic Approaches. Journal of Korean medical science30 (9), 1213–1225.
  2. Akaberi, M., et al. (2023). Ginkgo biloba: an update review on pharmacological, ethnobotanical, and phytochemical studies. Pharmacological Research-Modern Chinese Medicine, 100331.
  3. Barbalho, S. M., et al. (2022). Ginkgo biloba in the aging process: A narrative review. Antioxidants11 (3), 525.
  4. Belwal, T., et al. (2019). Ginkgo biloba. In Nonvitamin and nonmineral nutritional supplements (pp. 241-250). Academic Press.
  5. Wang, L., et al. (2011). An embryological study and systematic significance of the primitive gymnosperm Ginkgo biloba. Journal of Systematics and Evolution49 (4), 353-361.
  6. Fang, J., et al. (2020). Extraction, structure, and bioactivities of the polysaccharides from Ginkgo biloba: A review. International Journal of Biological Macromolecules,162, 1897-1905.
  7. WHO monographs on selected medicinal plants: folium Ginkgo. Vol. 1. Geneva: WHO; 1999, pp. 15467.
  8. Mahadevan, S., & Park, Y. (2008). Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. Journal of food science73 (1), R14-R19.
  9. De Souza, G. A., et al. (2020). Effects of Ginkgo biloba on diseases related to oxidative stress. Planta medica86 (06), 376-386.
  10. Grino, J. M. (1994). BN 52021: a platelet activating factor antagonist for preventing post-transplant renal failure: a double-blind, randomized study. Annals of internal medicine121 (5), 345-347.
  11. Ude, C., et al. (2013). Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients. Clinical pharmacokinetics52, 727-749.
  12. Zhu, T., et al. (2021). Classical active ingredients and extracts of Chinese herbal medicines: pharmacokinetics, pharmacodynamics, and molecular mechanisms for ischemic stroke. Oxidative medicine and cellular longevity2021.
  13. Jai, J., et al. (2022). In silico investigation of bioactive compounds from Ginkgo biloba as alternatives to non-steroidal anti-inflammatory drugs. Indonesian Journal of Life Sciences, 1-37.
  14. Chang, Y. H., et al. (2011). Effects of Ginkgo biloba extract on the expression of eNOS and the release of NO in mesenteric arterioles of senile rats. Zhonghua yi xue za zhi91 (35), 2501-2505.
  15. Singh, S. K., et al. (2019). Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics16 (3), 666-674.
  16. Darwesh, A. M., et al. (2021). Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?. Pharmacology & therapeutics219, 107703.
  17. Oppedisano, F., et al. (2020). The anti-inflammatory and antioxidant properties of n-3 PUFAs: Their role in cardiovascular protection. Biomedicines(9), 306.
  18. Abbott, K. A., et al. (2020). DHA-enriched fish oil reduces insulin resistance in overweight and obese adults. Prostaglandins, Leukotrienes and Essential Fatty Acids159, 102154.
  19. Hishikawa, D., et al. (2017). Metabolism and functions of docosahexaenoic acid‐containing membrane glycerophospholipids.FEBS letters591 (18), 2730-2744.
  20. Jacobs, M. L., et al. (2021). EPA and DHA differentially modulate membrane elasticity in the presence of cholesterol. Biophysical Journal120 (11), 2317-2329.
  21. Gutierrez-Mariscal, F. M., et al. (2020). Coenzyme Q10 supplementation for the reduction of oxidative stress: Clinical implications in the treatment of chronic diseases. International journal of molecular sciences21 (21), 7870.
  22. Fotino, A. D., et al. (2013). Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis. The American journal of clinical nutrition97 (2), 268-275.
  23. Raederstorff, D., et al. (2015). Vitamin E function and requirements in relation to PUFA. British Journal of Nutrition114 (8), 1113-1122.
  24. Chan, P. C., et al. (2007). Ginkgo biloba leave extract: biological, medicinal, and toxicological effects. Journal of environmental science and health part C25 (3), 211-244.
  25. Bhattaram, V. A., et al. (2002). Pharmacokinetics and bioavailability of herbal medicinal products. Phytomedicine9, 1-33.